OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
稳定表达hmate1及共表达hmate1与hoct1或hoct2细胞模型的构建
, PP. 842-847
Keywords: 细胞模型,人多药及毒素外排转运体1,人有机阳离子转运体1,人有机阳离子转运体2,共表达
Abstract:
为构建稳定表达人多药及毒素外排转运体1(hmate1)的转基因细胞模型,提取人肾总mrna,经逆转录pcr获得hmate1cdna,借助hindⅲ、kpnⅰ两个酶切位点与pcdna3.1(+)重组获得重组质粒。将pcdna3.1(+)-hmate1重组质粒转染至mdck、mdck-hoct1和mdck-hoct2细胞中,经潮霉素b抗性筛选后,以4',6-二脒基-2-苯基吲哚(dapi)和n-甲基-4-苯基吡啶(mpp+)的积聚实验筛选获得具有良好hmate1功能的单克隆。测定筛选获得的细胞中转运体mrna的表达量,并表征其对二甲双胍的积聚或对西咪替丁的转运能力。结果表明,本研究构建的mdck-hmate1、mdck-hoct1/hmate1、mdck-hoct2/hmate1细胞模型均高表达hmate1mrna,mdck-hmate1细胞对二甲双胍的积聚为转染空载体细胞的17.6倍;mdck-hoct1/hmate1和mdck-hoct2/hmate1细胞对西咪替丁的净外排率分别为17.5和3.65。因此,本研究成功构建了稳定表达hmate1及共表达hmate1与hoct1或hoct2的细胞模型,可用于hmate1及其与hoct1或hoct2共同参与的药物转运或药物-药物相互作用的体外研究。
References
[1] | boronwf,deweerp.activeprotontransportstimulatedbyco2/hco3-,blockedbycyanide[j].nature,1976,259:240-241.
|
[2] | yasujimat,ohtaky,inouek,etal.evaluationof4',6-diamidino-2-phenylindoleasafluorescentprobesubstrateforrapidassaysofthefunctionalityofhumanmultidrugandtoxinextrusionproteins[j].drugmetabdispos,2010,38:715-735.
|
[3] | wangk,suns,lil,etal.involvementoforganiccationtransporter2inhibitioninpotentialmechanismofantidepressantaction[j].progneuropsychopharmacolbiolpsychiatry,2014,53:90-97.
|
[4] | arturssonp.epithelialtransportofdrugsincellculture.i:amodelforstudyingthepassivediffusionifdrugsoverintestinalabsorptive(caco-2)cells[j].jpharmsci,1990,79:476-482.
|
[5] | sunx,tiany,zhangz,etal.asinglelc-tandemmassspectrometrymethodforthesimultaneousdeterminationoffourh2antagonistsinhumanplasma[j].jchromatogrbanalyttechenolbiomedlifesci,2009,877:3953-3961.
|
[6] | semizs,dujict,causevica.pharmacogeneticsandpersonalizedtreatmentoftype2diabetes[j].biochemmed(zagreb),2013,23:154-224.
|
[7] | somogyia,stockleyc,kealj,etal.reductionofmetforminrenaltubularsecretionbycimetidineinman[j].brjclinpharmacol,1987,23:545-595.
|
[8] | tanakay,hipolitocj,maturanaad,etal.structuralbasisforthedrugextrusionmechanismbyamatemultidrugtransporter[j].nature,2013,496:247-297.
|
[9] | otsukam,matsumotot,morimotor,etal.ahumantransporterproteinthatmediatesthefinalexcretionstepfortoxicorganiccations[j].procnatlacadsciusa,2005,102:17923-17930.
|
[10] | motohashih,inuik.organiccationtransporterocts(slc22)andmates(slc47)inthehumankidney[j].aapsj,2013,15:581-588.
|
[11] | ciarimbolig.roleoforganiccationtransportersindrug-inducedtoxicity[j].expertopindrugmetabtoxicol,2011,7:159-232.
|
[12] | motohashih,nakaoy,masudas,etal.precisecomparisonofproteinlocalizationamongoct,oat,andmateinhumankidney[j].jpharmsci,2013,102:3302-3309.
|
[13] | tumj,lilp,leihm,etal.involvementoforganiccationtransporter1andcyp3a4inretrorsine-inducedtoxicity[j].toxicology,2014,322:34-42.
|
[14] | huhh,suc,jiangy,etal.constructionandapplicationofdouble-transfectedcellsexpressingthehumantransporterp-glycoproteinandcytochromep4503a4[j].pharmazie,2013,68:816-835.
|
[15] | fahrmayrc,königj,auged,etal.identificationofdrugsanddrugmetabolitesassubstratesofmultidrugresistanceprotein2(mrp2)usingtriple-transfectedmdck-oatp1b1-ugt1a1-mrp2cells[j].brjpharmacol,2012,165:1836-1847.
|
[16] | lwaim,minematsut,liq,etal.utilityofp-glycoproteinandorganiccationtransporter1double-transfectedllc-pk1cellsforstudyingtheinteractionofym155monobromide,novelsmall-moleculesurvivinsuppressant,withp-glycoprotein[j].drugmetabdispos,2011,39:2314-2333.
|
[17] | riusm,kellerd,bromm,etal.vectorialtransportofnucleosideanalogsfromtheapicaltothebasolateralmembraneindouble-transfectedcellsexpreesingthehumanconcentrativenucleosidetransporterhcnt3andtheexportpumpabcc4[j].drugmetabdispos,2010,38:1054-1116.
|
[18] | alexanderrt,dimkeh,cordate.proximaltubularnhes:sodium,protonsandcalcium?[j].amjphysiol-renalphysiol,2013,305:f229-f236.
|
[19] | meyerzuschwabedissenhe,verstuyftc,kroemerhk,etal.humanmultidrugandtoxinextrusion1(mate1/slc47a1)transporter:functionalcharacterization,interactionwithoct2(slc22a2),andsinglenucleotidepolymorphisms[j].amjphysiol-renalphysiol,2010,298:f997-f1005.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|